Actively Recruiting

Phase Not Applicable
Age: 6Months +
All Genders
NCT07191457

Safety and Efficacy of Head-lice Treatments Elimax Green Lotion and Walgreens Lice Killing Shampoo

Led by Oystershell NV · Updated on 2025-09-24

86

Participants Needed

1

Research Sites

25 weeks

Total Duration

On this page

Sponsors

O

Oystershell NV

Lead Sponsor

L

Lice Solutions Resource Network (LSRN) Research

Collaborating Sponsor

AI-Summary

What this Trial Is About

Compare efficacy and safety of Elimax Green Lotion Emogreen (RID SUper Max Solution) to that of Walgreens Lice Killing Shampoo against headlice in infested individuals. Involved subjects aged 6 months and older, of both genders, with a confirmed diagnosis of head lice infestation are included. Local and global tolerability, skin and eye irritation are monitored throughout the study. Any adverse events will be monitored and recorded.

CONDITIONS

Official Title

Safety and Efficacy of Head-lice Treatments Elimax Green Lotion and Walgreens Lice Killing Shampoo

Who Can Participate

Age: 6Months +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female gender.
  • Age 6 months or older at enrollment.
  • Confirmed active head lice infestation with at least 5 live lice and 5 live nits.
  • Good general health based on medical history.
  • Agree to use Johnson's baby shampoo to rinse out the product as instructed.
  • Agree not to shampoo, wash, or rinse hair or scalp for 24 hours after treatment.
  • Agree not to cut or chemically treat hair during the study.
  • Willingness to follow all study instructions and attend follow-up appointments.
  • Agree not to use any other lice treatments or medicated hair products during the study.
  • Parent or guardian agrees to have other family members screened for head lice.
  • Have a stable residence or agree to remain at current residence during the study.
  • Provide written informed consent; children 6-11 years will provide assent.
Not Eligible

You will not qualify if you...

  • Use of any head lice treatment or home remedy within 14 days before screening.
  • Use of any topical medication on hair or scalp within 48 hours before screening.
  • Use of systemic or topical drugs that may interfere with study results.
  • Known allergies to active ingredients or cosmetic products.
  • Visible skin or scalp conditions at treatment site that interfere with evaluation.
  • Chronic scalp disorders.
  • Inability to understand study requirements or likely poor compliance.
  • Pregnant or nursing females.
  • Hair longer than waist length.
  • Prior participation in this or any investigational trial within 14 days.
  • Direct affiliation with study personnel or employees related to the study.
  • Families with 4 or more household members.
  • Presence of dreadlocks or clip-in hair that cannot be removed.
  • Hair difficult to work with as assessed by study staff.
  • Families where some lice-infested members decline enrollment.
  • Receiving or expected to receive antibiotic therapy during the study.
  • More than one working subject per household excluded if lice-free.
  • All household members must be screened; if others decline enrollment, family is excluded.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

LSRN Research

Enid, Oklahoma, United States, 73701

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here